Skip to main content
. 2022 Aug 13;22:226. doi: 10.1186/s12874-022-01666-x

Fig. 6.

Fig. 6

Age-specific cumulative incidence of death from prostate cancer under DES and placebo and their difference for individuals with normal daily activity, no history of cardiovascular disease and hemoglobin level lower than 12 (g/100ml) by time since randomisation, with 95% confidence intervals